20 unchanged sentences
Payment of cash dividends, if any, in the future will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant.
−Removed: Stock Performance Graph
−Removed: The following graph shows the total stockholder’s return on an investment of $100 in cash at market close on March 23, 2016 (the first day of trading of our common stock), through December 31, 2020 for (i) our common stock, (ii) the Nasdaq Composite Index and (iii) the Nasdaq Biotechnology Index.
−Removed: Pursuant to applicable Securities and Exchange Commission rules, all values assume reinvestment of the full amount of all dividends, however, no dividends have been declared on our common stock to date.
−Removed: The stockholder return shown on the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder return.
−Removed: This graph and the table below it shall not be deemed “soliciting material” or be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any
−Removed: of our filings under the Securities Act of 1933, as amended (the “Securities Act”), whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
−Removed: $100 investment in stock or index
−Removed: Corvus (CRVS)
−Removed: NASDAQ Composite Index (IXIC)
−Removed: NASDAQ Biotech Index ( ˄ NBI)
Securities Authorized for Issuance Under Equity Compensation Plans
3 unchanged sentences
In November 2019, we entered into an exchange agreement (the “Exchange Agreement”) with entities affiliated with Biotechnology Value Fund, L.P.
−Removed: (the “Exchanging Stockholders”), pursuant to which we exchanged an aggregate of 1,458,000 shares of our common stock owned by the Exchanging Stockholders for warrants (the “Exchange Warrants”) to purchase an aggregate of 1,458,000 shares of common stock (subject to adjustment in the event of stock splits, recapitalizations and other similar events affecting common stock), with an exercise price of $0.0001 per share.
+Added: (the “Exchanging Stockholders”), pursuant to which we exchanged an aggregate of 1,458,000 shares of our common stock owned by the Exchanging Stockholders for warrants (the “Exchange
+Added: Warrants”) to purchase an aggregate of 1,458,000 shares of common stock (subject to adjustment in the event of stock splits, recapitalizations and other similar events affecting common stock), with an exercise price of $0.0001 per share.
The Exchange Warrants were issued without registration under the Securities Act of 1933, as amended (the “Securities Act”), in reliance on the exemption from registration contained in Section 3(a)(9) of the Securities Act.
+Added: The Exchanging Stockholders exercised the Exchange Warrants pursuant to a cashless exercise on September 20, 2021 and we issued an aggregate of 1,457,947 shares of common stock to such Exchanging Stockholders.
Issuer Purchases of Equity Securities by the Issuer and Affiliated Purchasers
15 unchanged sentences
Gain on deconsolidation of Angel Pharmaceuticals
+Added: Sublease income - related party
Loss from equity method investment
3 unchanged sentences
Unrealized gain (loss) on marketable securities
+Added: Cumulative foreign currency translation adjustment
Comprehensive loss
5 unchanged sentences
Convertible preferred stock
−Removed: Total stockholders’ equity (deficit)
+Added: Total stockholders’ equity
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.